Stay updated on PEGPH20 & Pembro in High Metastatic PDAC Clinical Trial
Sign up to get notified when there's something new on the PEGPH20 & Pembro in High Metastatic PDAC Clinical Trial page.

Latest updates to the PEGPH20 & Pembro in High Metastatic PDAC Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedLocations section added with Arizona, California, New Jersey, Washington, and Wisconsin, indicating current recruitment sites. This reflects updated site recruitment information for the study.SummaryDifference0.6%

- Check25 days agoNo Change Detected
- Check46 days agoChange Detected- Revision updated from v3.2.0 to v3.3.2; no changes to page content or study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check54 days agoChange DetectedFunding-lapse notice regarding government operations was removed from the page; all trial details and links remain unchanged.SummaryDifference0.3%

- Check75 days agoChange DetectedNo significant changes detected; the update appears to involve minor formatting and layout adjustments on the Study Details page without altering core study information (eligibility criteria, endpoints, or enrollment details). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check97 days agoChange Detected- Added a government funding notice with operational details and links; - Updated version to v3.2.0; - Removed reference to v3.1.0.SummaryDifference2%

- Check104 days agoChange DetectedUpdated version to v3.1.0 and added multiple contact emails and phone numbers; older version reference v3.0.2 was removed.SummaryDifference0.0%

Stay in the know with updates to PEGPH20 & Pembro in High Metastatic PDAC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PEGPH20 & Pembro in High Metastatic PDAC Clinical Trial page.